The use of substances for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases

Details for Australian Patent Application No. 2008290825 (hide)

Owner Merz Pharma GmbH & Co. KGaA

Inventors Russ, Hermann

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008290825

PCT Pub. Number WO2009/024346

Priority 07253904.2 02.10.07 EP; 60/965,650 21.08.07 US

Filing date 21 August 2008

Wipo publication date 26 February 2009

Acceptance publication date 12 July 2012

International Classifications

A61K 38/08 Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61P 27/06 Drugs for disorders of the senses

Event Publications

25 February 2010 PCT application entered the National Phase

  PCT publication WO2009/024346 Priority application(s): WO2009/024346

12 July 2012 Application Accepted

  Published as AU-B-2008290825

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008290827-Method for activating regulatory t-cells

2008290807-Drill guide with a limit stop